Clinical Trials Logo

Clinical Trial Summary

The study to evaluate the consistency of oscillometry and spirometry test results in patients with confirmed or suspected asthma or COPD, it is a multi-centre clinical study. sponsor by Astrazeneca Investment(China) Co.,LTD.


Clinical Trial Description

800 patients, including suspected or confirmed asthma, suspected or confirmed COPD, will be enrolled in nationwide multiple study centres. Enrolling suspected and confirmed subject in an approximate1:1 rate in centre-level. About 100 subjects were enrolled at the leader site, while about 14 subjects were enrolled at other sites. To evaluate the consistency of oscillometry and spirometry test results in patients with confirmed or suspected asthma or COPD. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06172777
Study type Observational
Source AstraZeneca
Contact AstraZeneca Clinical Study Information Center
Phone 1-877-240-9479
Email information.center@astrazeneca.com
Status Recruiting
Phase
Start date February 8, 2024
Completion date August 9, 2024